Amelioration of female menopausal syndrome by intravenous administration of autologous menstrual blood-derived stem cells
The present results suggest that the administration of MenSCs improved menopausal symptoms and regulated hormonal balance without any serious adverse events. This is the first report on the promising therapeutic potential of cell-based therapy using autologous MenSCs for female menopausal syndrome.
Authors
- Takayuki Yoshimoto (ORCID: https://orcid.org/0000-0002-2847-0341)
- Charlie Xiang
- Seiji Ogawa
- Hiromi Izawa
- Ichiro Hisanaga
Institutions
- Dai Nippon Printing (Japan) (JP)
- Ritsumeikan University (JP)
- Tokyo Medical University (JP)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Japan Spaceguard Association (JP)
- National Clinical Research Center for Digestive Diseases (CN)
- Tokyo Medical Center (JP)
- First Affiliated Hospital Zhejiang University (CN)
- State Key Laboratory of Diagnosis and Treatment of Infectious Diseases
Publication Details
- Journal
- Regenerative Therapy
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1016/j.reth.2025.03.009
- Citations
- 2
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 3.25